Gong, Ningqiang https://orcid.org/0000-0002-9444-8505
Zhong, Wenqun
Alameh, Mohamad-Gabriel https://orcid.org/0000-0002-5672-6930
Han, Xuexiang https://orcid.org/0000-0003-0011-5222
Xue, Lulu https://orcid.org/0000-0001-5719-1336
El-Mayta, Rakan https://orcid.org/0000-0002-5855-233X
Zhao, Gan https://orcid.org/0000-0002-8043-6036
Vaughan, Andrew E. https://orcid.org/0000-0001-5740-643X
Qin, Zhiyuan
Xu, Fengyuan
Hamilton, Alex G. https://orcid.org/0000-0002-9810-5630
Kim, Dongyoon
Xu, Junchao
Kim, Junhyong https://orcid.org/0000-0002-7726-8246
Teng, Xucong
Li, Jinghong https://orcid.org/0000-0002-0750-7352
Liang, Xing-Jie https://orcid.org/0000-0002-4793-1705
Weissman, Drew https://orcid.org/0000-0002-1501-6510
Guo, Wei https://orcid.org/0000-0002-9251-0360
Mitchell, Michael J. https://orcid.org/0000-0002-3628-2244
Funding for this research was provided by:
Foundation for the National Institutes of Health (DP2TR002776)
National Science Foundation (CBET-2145491)
Article History
Received: 23 January 2023
Accepted: 25 June 2024
First Online: 2 September 2024
Competing interests
: N.G., M.J.M., W.Z. and W.G. have filed a patent (Lipid nanoparticle (LNP) compositions and methods for delivering therapeutic agents to tumour cells) related to this paper.